ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1,3,Left ventricular dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
1,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
3,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
4,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4,7,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
4,8,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
6,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
8,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
9,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
10,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
11,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
11,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
12,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
12,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
13,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
14,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
14,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
14,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,4,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
14,5,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
14,6,Sclerodactylia,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,7,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
15,1,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
16,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
17,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
17,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
18,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
19,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
20,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
21,2,Headache,Headaches NEC,Headaches,Nerv,N
21,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
22,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
22,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
23,1,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
24,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
24,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
24,3,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
24,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
25,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
26,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
27,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
28,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
28,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
29,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
30,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
30,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
31,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
31,4,Subclavian artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
32,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
33,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
33,2,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
34,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
34,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
34,3,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
34,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
36,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
37,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
37,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
37,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
37,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
37,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
37,7,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
37,8,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
37,9,Sudden cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
38,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
38,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,1,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
40,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
40,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
40,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
40,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
40,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
40,6,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
41,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
42,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
43,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
43,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
43,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
43,4,Headache,Headaches NEC,Headaches,Nerv,N
43,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
44,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
44,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
44,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
44,4,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
44,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
45,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
45,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
45,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
47,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
48,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
49,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
50,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
50,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
51,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
52,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
52,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
53,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
53,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
53,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
54,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
55,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
55,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
56,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
57,1,Headache,Headaches NEC,Headaches,Nerv,N
57,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
57,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
58,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
58,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
58,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
59,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
59,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
59,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
59,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
59,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
60,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
60,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
60,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
60,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
60,5,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
60,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
60,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
60,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
61,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
61,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
61,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
62,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
62,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
63,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
63,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
63,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
64,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
64,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
65,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
65,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
65,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
66,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
66,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
66,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
67,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
67,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
67,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
68,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
68,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
69,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
69,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
69,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
70,2,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
70,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
70,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
71,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
72,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
73,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
74,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
75,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
75,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
76,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
76,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
76,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
76,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
77,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
77,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
77,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
77,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
77,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
77,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
77,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
78,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
80,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
81,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
81,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
81,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
82,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
83,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
83,2,Organ transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
84,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
84,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
84,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
85,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
87,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
88,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
89,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
90,1,Device alarm issue,Device information output issues,Device issues,Prod,N
90,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
91,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
92,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
92,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
93,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
93,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
94,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
94,2,Headache,Headaches NEC,Headaches,Nerv,N
95,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
95,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
95,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
96,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
99,1,Intestinal strangulation,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
100,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
101,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
101,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
101,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
102,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
103,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
103,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
103,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
103,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
104,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
104,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
104,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
105,1,Device infusion issue,Device malfunction events NEC,Device issues,Prod,N
105,2,Vascular device occlusion,Vascular complications associated with device,Complications associated with device,Genrl,N
106,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
106,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
106,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
107,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
108,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
109,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
110,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
112,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
113,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
115,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
115,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
115,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
116,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
117,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
118,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
119,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
120,1,Organ transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
121,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
122,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
123,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
124,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
125,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
125,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
125,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
126,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
127,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
128,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
131,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
132,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
132,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
133,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
133,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
133,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
134,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
135,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
136,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
137,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
138,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
139,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
140,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
140,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
141,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
142,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
143,1,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
144,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
145,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
146,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
147,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
148,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
149,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
150,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
151,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
152,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
153,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
154,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
155,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
156,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
157,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
158,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
158,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
159,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
160,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
161,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
162,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
163,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
163,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
164,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
164,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
165,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
165,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
166,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
167,1,Hospice care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
167,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
168,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
168,3,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
169,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
170,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
171,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
171,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
171,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
172,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
172,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
174,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
175,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
176,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
177,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
177,2,Headache,Headaches NEC,Headaches,Nerv,N
178,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
179,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
179,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
179,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
179,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
180,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
181,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
181,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
182,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
182,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
182,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
183,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
185,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
185,2,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
185,3,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
185,4,Infusion site warmth,Infusion site reactions,Administration site reactions,Genrl,N
186,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
188,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
189,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
190,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
191,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
192,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
193,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
194,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
